C K Li1, B C K Choi, T W Wong. 1. Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 120 Colonnade Road, Ottawa, Ont., Canada K1A 0K9.
Abstract
BACKGROUND: While influenza vaccination has been widely used in developed countries to reduce mortality and morbidity in high-risk populations, the lack of regional data on the health burden of influenza and the uncertainty of the applicability of data from temperate areas have been major impediments to establishing an evidence-based policy on the wider use of influenza vaccine in tropical and subtropical regions of the world. OBJECTIVES: The aim of this study was to estimate the annual excess deaths and hospitalizations related to influenza in the Hong Kong Special Administrative Region (HKSAR) for the years 1999 and 2000. STUDY DESIGN AND METHODS: Correlation and regression models were used to estimate the excess deaths and hospitalizations related to influenza in the general population of HKSAR for the years 1999 and 2000, using routinely collected mortality and hospitalization data, and virological laboratory data collected by the HKSAR Influenza Surveillance System. RESULTS: The annual mean excess numbers of deaths related to influenza in Hong Kong were estimated to be 613 for pneumonia and influenza, and 2302 for respiratory and circulatory diseases. The mean excess numbers of hospitalizations attributable to influenza were 4051 for pneumonia and influenza, and 15,873 for respiratory and circulatory diseases. The crude influenza-related mortality and hospitalization rates in Hong Kong, a subtropical area, exceeded those documented in temperate regions. CONCLUSIONS: The finding of significant mortality and morbidity related to influenza in a subtropical area is in accordance with the results of previous studies in tropical and subtropical regions. This simple methodology can be used for the development of influenza immunization policy in many developing countries in tropical and subtropical regions. The enormous potential of influenza vaccination in saving lives and reducing suffering warrants serious consideration of the expanded use of influenza vaccine in tropical and subtropical regions.
BACKGROUND: While influenza vaccination has been widely used in developed countries to reduce mortality and morbidity in high-risk populations, the lack of regional data on the health burden of influenza and the uncertainty of the applicability of data from temperate areas have been major impediments to establishing an evidence-based policy on the wider use of influenza vaccine in tropical and subtropical regions of the world. OBJECTIVES: The aim of this study was to estimate the annual excess deaths and hospitalizations related to influenza in the Hong Kong Special Administrative Region (HKSAR) for the years 1999 and 2000. STUDY DESIGN AND METHODS: Correlation and regression models were used to estimate the excess deaths and hospitalizations related to influenza in the general population of HKSAR for the years 1999 and 2000, using routinely collected mortality and hospitalization data, and virological laboratory data collected by the HKSAR Influenza Surveillance System. RESULTS: The annual mean excess numbers of deaths related to influenza in Hong Kong were estimated to be 613 for pneumonia and influenza, and 2302 for respiratory and circulatory diseases. The mean excess numbers of hospitalizations attributable to influenza were 4051 for pneumonia and influenza, and 15,873 for respiratory and circulatory diseases. The crude influenza-related mortality and hospitalization rates in Hong Kong, a subtropical area, exceeded those documented in temperate regions. CONCLUSIONS: The finding of significant mortality and morbidity related to influenza in a subtropical area is in accordance with the results of previous studies in tropical and subtropical regions. This simple methodology can be used for the development of influenza immunization policy in many developing countries in tropical and subtropical regions. The enormous potential of influenza vaccination in saving lives and reducing suffering warrants serious consideration of the expanded use of influenza vaccine in tropical and subtropical regions.
Authors: Li Li; Jessica Y Wong; Peng Wu; Helen S Bond; Eric H Y Lau; Sheena G Sullivan; Benjamin J Cowling Journal: Am J Epidemiol Date: 2018-02-01 Impact factor: 4.897
Authors: Daniel R Feikin; Maurice O Ope; Barrack Aura; James A Fuller; Stella Gikunju; John Vulule; Zipporah Ng'ang'a; M Kariuki Njenga; Robert F Breiman; Mark Katz Journal: Bull World Health Organ Date: 2012-04-01 Impact factor: 9.408
Authors: Danjuan Li; Reiko Saito; Mai T Q Le; Hang L K Nguyen; Yasushi Suzuki; Yugo Shobugawa; Duc T Dinh; Phuong V M Hoang; Huong T T Tran; Ha K Nghiem; Long T Hoang; Lien P Huynh; Hien T Nguyen; Makoto Nishikawa; Hiroshi Suzuki Journal: J Clin Microbiol Date: 2007-10-17 Impact factor: 5.948
Authors: Justin R Ortiz; Viviana Sotomayor; Osvaldo C Uez; Otavio Oliva; Deborah Bettels; Margaret McCarron; Joseph S Bresee; Anthony W Mounts Journal: Emerg Infect Dis Date: 2009-08 Impact factor: 6.883